Surgical Specialties Corporation, a leading provider of branded, private label, and OEM medical devices for advanced surgical wound closure and ophthalmology, has been awarded a group purchasing agreement with Premier, Inc. to provide its recently expanded portfolio of suture products to Premier’s extensive network of 3,400 hospitals and 110,000 healthcare providers.  

“We are thrilled to work with Premier to provide our new Sharpoint Plus Surgical Suture portfolio to its members,” says Brennan Marilla, chief commercial officer of Surgical Specialties Corporation. “The addition of these recently enhanced and expanded, yet more affordable suture product lines are consistent with Premier’s goal of providing high quality outcomes at a lower cost. This award represents an important milestone in our goal of increasing customer access to our products.”

The three year agreement will be effective on April 1, 2015. The start of this new contract coincides with the planned expansion of the Sharpoint™ line of sutures for use in more advanced surgical procedures, in addition to the current micro and ophthalmic surgery offerings. The new Sharpoint Plus Surgical Suture incorporates a new needle design and expanded options, created for and with the support of multi-specialty surgeon users. The upgraded needles offer smooth penetration on first and multiple passes, a desired quality for more advanced wound closure applications, such as plastic surgery.  

Sharpoint Plus Surgical Suture joins Sharpoint Microsuture and Opthalmic Suture, and Quill Knotless Tissue-Closure, a market leading barbed suture device, to allow for a comprehensive portfolio of advanced wound closure products to be purchased by Premier members from Surgical Specialities Corp and its‘ nationwide network of authorised distributors.